The novel proteomic signature for cardiac allograft vasculopathy

AIMS: Cardiac allograft vasculopathy (CAV) is the major long‐term complication after heart transplantation, leading to mortality and re‐transplantation. As available non‐invasive biomarkers are scarce for CAV screening, we aimed to identify a proteomic signature for CAV. METHODS AND RESULTS: We meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Dongmei, Trenson, Sander, Van Keer, Jan M., Melgarejo, Jesus, Cutsforth, Ella, Thijs, Lutgarde, He, Tianlin, Latosinska, Agnieszka, Ciarka, Agnieszka, Vanassche, Thomas, Van Aelst, Lucas, Janssens, Stefan, Van Cleemput, Johan, Mischak, Harald, Staessen, Jan A., Verhamme, Peter, Zhang, Zhen‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934921/
https://www.ncbi.nlm.nih.gov/pubmed/35005846
http://dx.doi.org/10.1002/ehf2.13796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934921/
https://www.ncbi.nlm.nih.gov/pubmed/35005846
http://dx.doi.org/10.1002/ehf2.13796

Ejemplares similares